Top Markets
Coin of the day
Intercept Pharmaceuticals, Inc. Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals, Inc.

ICPT
Rangering i aksjer #12018
Intercept Pharmaceuticals, Inc. is a biopharmaceutical firm specializing in the... Intercept Pharmaceuticals, Inc. is a biopharmaceutical firm specializing in the advancement and market launch of therapies designed to treat progressive, non-viral liver conditions. Its operational reach spans the United States, Europe, and Canada. The company currently markets Ocaliva, a medication functioning as a farnesoid X receptor (FXR) agonist. This drug is approved for the treatment of primary biliary cholangitis (PBC) in adults, specifically when administered alongside ursodeoxycholic acid. Beyond its existing approved indications, Intercept is actively investigating Ocaliva's potential for additional uses, notably including nonalcoholic steatohepatitis (NASH). Concurrently, it is progressing other drug candidates through various clinical and preclinical stages of development. In a collaborative effort, the company holds a licensing agreement with Aralez Pharmaceuticals Canada Inc. to develop and commercialize bezafibrate in the United States. Intercept distributes its products through a dual approach, utilizing both its proprietary commercial organization and a network of external third-party distributors. The company was founded in 2002 and is headquartered in New York, New York.
Aksjekurs
$19.00
Sist synkronisert: 2023-11-14
Markedsverdi
$629.64M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Intercept Pharmaceuticals, Inc. (ICPT)

Kategori

Aksjeprishistorikk for Intercept Pharmaceuticals, Inc. (ICPT)
Høyeste sluttskurs: $18.99 den 2023-11-01

Laveste sluttskurs: $19.35 den 2012-10-01
Aksjeprishistorikk for Intercept Pharmaceuticals, Inc. fra 2012 til 2026
Årlig aksjeprisytelse
År Ytelse
2023 39.35%
2022 -16.08%
2021 -46.76%
2020 -74.21%
2019 16.21%
2018 65.23%
2017 -41.82%
2016 -32.31%
2015 8.19%
2014 138.13%
2013 92.89%
2012 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.36 -12.82%
AU
$138.18 473.58%
US
$759.27 7.20%
CH